View in EDS

Garadacimab in hereditary angioedema due to normal C1INH with F12/PLG mutations.

Saved in:
Bibliographic Details
Title: Garadacimab in hereditary angioedema due to normal C1INH with F12/PLG mutations.
Authors: Cohn DM; Department of Vascular Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands. Electronic address: d.m.cohn@amsterdamumc.nl., Reshef A; Allergy, Immunology, and Angioedema Center, Barzilai University Hospital, Ashkelon, Israel., Staubach P; Department of Dermatology, University Medical Center Mainz, Johannes Gutenberg University, Mainz, Germany., Lumry WR; AARA Research Center, Dallas, Tex., Feuersenger H; CSL Innovation GmbH, Marburg, Germany., Jacobs I; CSL Behring, King of Prussia, Pa., Pragst I; CSL Innovation GmbH, Marburg, Germany., Zuraw B; Division of Allergy and Immunology, Department of Medicine, University of California San Diego, La Jolla, Calif; San Diego VA Healthcare, La Jolla, Calif., Bork K; Department of Dermatology, University Medical Center Mainz, Johannes Gutenberg University, Mainz, Germany.
Source: The Journal of allergy and clinical immunology [J Allergy Clin Immunol] 2025 Dec; Vol. 156 (6), pp. 1756-1760.e4. Date of Electronic Publication: 2025 Aug 26.
Publication Type: Journal Article; Clinical Trial, Phase II; Clinical Trial, Phase III; Multicenter Study
Journal Info: Publisher: Mosby Country of Publication: United States NLM ID: 1275002 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6825 (Electronic) Linking ISSN: 00916749 NLM ISO Abbreviation: J Allergy Clin Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1097-6825
DOI:10.1016/j.jaci.2025.08.005